Stock Market
Stock market news, analysis, and trading insights
700% Net Profit: NBFC Stock Hits 5% Upper Circuit After Announcing Q3 Results
Synopsis: CitiPort Financial Services Ltd, an NBFC in India, hit a 5% upper circuit after reporting a 700% YoY net profi...
Railway Stock Falls 3% After Cancellation of Multiple Projects Worth ₹609 Cr
Synopsis:-  The stock fell nearly 3% after the cancellation of Bihar-based education projects worth  Rs 609.56...
Stock Falls 8% After Clarification on Blackstone, KKR, and Others Buying Stake
Synopsis: Redtape plunged sharply after the company denied rumours of it selling a stake to PE giants like Blackstone,...
Solar Pump Stock Jumps After Securing ₹120 Cr Order from Karnataka Government
SYNOPSIS: Oswal Pumps secured a Rs. 119.92 crore PM-KUSUM B order from KREDL to supply and install 3,263 off-grid solar...
How will Torrent Pharma benefit from the acquisition of JB Chemicals?
Synopsis: Torrent Pharma’s acquisition of JB Chemicals will raise its domestic market rank from 7th to 5th, with Rs. 12,...
VBL, HDFC Bank, and 3 Other Stocks in Which Govt. of Singapore Reduced Stake in Q3
Synopsis: In Q3 FY26, the Government of Singapore exited its stake in PG Electroplast and Castrol India, while stake red...
Why did Puravankara shares skyrockets 12% today?
SYNOPSIS: Puravankara reported steady Q3 FY26 pre-sales growth, improved realisations and collections, alongside strong...
Hidden Gem: Market Leader stock in Polymer Compounds Manufacturing to Keep on Your Radar
Synopsis:- India’s largest listed polymer compound player is scaling aggressively, with capacity set to cross 270,000 MT...
Tata Technologies Share Price Down Nearly 50% Since Listing: 6 Key Reasons Explained
Synopsis: Tata Technologies entered the market on huge excitement around EVs and the Tata name, but reality turned out s...
5 Pharma stocks in which Jefferies sees strong business growth ahead; Check the stock targets
Synopsis: Jefferies is positive on select Indian pharma stocks, naming Ajanta Pharma, Sun Pharma, Mankind Pharma, Zydus...
Is Now the Right Time to Buy Infosys Ahead of Q3 Results? Here’s What Motilal Oswal Says
SYNOPSIS: Motilal Oswal sees CY26 as the IT growth bottom, with Infosys well placed for an AI-led rebound through FY27-F...
2 IT Stocks to Buy now for up to 35% upside, Recommended by Motilal Oswal
Synopsis: Motilal Oswal Financial Services recommends Tata Consultancy Services Limited and HCL Technologies Limited, ci...
Popular Posts from Stock Market
Technical View: Nifty, Bank Nifty & Sensex Trade Setup and Key levels to watch for 4th December
2 Penny stocks jump after securing new work orders
Explained: Why Waaree Energies shares are trading at 25% discount?
3 Stocks in which promoter increased their stake in October & November